Skip to main content
OpenTrials

Clinical trial condition

Urinary Bladder, Overactive

Explore clinical trials studying Urinary Bladder, Overactive. Study availability and eligibility vary by location and protocol.

89 public trials 9 recruiting studies
Refine in advanced search Browse all conditions

Urinary Bladder, Overactive trial results

Completed

A Study to Evaluate the Efficacy, Safety and Tolerability of Mirabegron and Solifenacin Succinate Alone and in Combination for the Treatment of Overactive Bladder

NCT01340027

Conditions
Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Lower Urinary Tract Symptoms, +10 more
Locations
  • BY37101 Minsk, Belarus
  • BY37102 Minsk, Belarus
  • BY37103 Minsk, Belarus
  • BY37104 Vitebsk, Belarus
View all 133 locations
View Trial Details
Completed

Efficacy and Safety Study of GSK1358820 in Japanese Patients With Urinary Incontinence Due to Neurogenic Detrusor Overactivity

NCT02849418

Conditions
Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Lower Urinary Tract Symptoms, +10 more
Locations
  • GSK Investigational Site Aomori, Japan
  • GSK Investigational Site Fukuoka, Japan
  • GSK Investigational Site Hokkaido, Japan
  • GSK Investigational Site Hyōgo, Japan
View Trial Details
Completed

A Study to Evaluate the Efficacy of Tolterodine on Specific Symptoms in Adult Patients With Overactive Bladder.

NCT00645281

Conditions
Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Lower Urinary Tract Symptoms, +8 more
Locations
  • Pfizer Investigational Site Birmingham, Alabama, United States
  • Pfizer Investigational Site Birmingham, Alabama, United States
  • Pfizer Investigational Site Birmingham, Alabama, United States
  • Pfizer Investigational Site Huntsville, Alabama, United States
View all 96 locations
View Trial Details
Completed

Efficacy and Safety of GSK1358820 in Subjects With Overactive Bladder

NCT02820844

Conditions
Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Lower Urinary Tract Symptoms, +10 more
Locations
  • GSK Investigational Site Aichi, Japan
  • GSK Investigational Site Aichi, Japan
  • GSK Investigational Site Chiba, Japan
  • GSK Investigational Site Chiba, Japan
View all 48 locations
View Trial Details

Related conditions